First off listen clearly to Wittenberg and read our previous press releases it says clear as day that we CURRENTLY have licensing agreements with Abbott and Inverness and I believe that Abbott's lawyers would never allow us to make this claim if it were untrue! I know just mentioning there name on any press release they demanded clearance with their lawyers. I was told some of the previous press releases were delayed until they received such said approval. I know we have proven the technology works this is not a big charade or hoax. I agree it would be in shareholders best interest to clarify our agreement with Abbott. Bottom line to increase the share price 4 things have to happen: 1)Divulge our money situation and where he plans to fund the continuation of our operations. 2)Clarify the Abbott agreement. 3)Find out why the share price is where it is at (shorting or lose of shareholder confidence). 4)When will we see commercialization in Recaf and where? US or outside the US? When these questions are answered (and I trust they will) we can put in a bottom and look toward positive news as we approach the ISOBM. Just my 2 cents.
News 
Market Data 
Discover 
